Abstract
Lack of high-molecular-weight (HMW) von Willebrand factor (vWF) multimers is one of the most critical causes of bleeding complication in long-term management of continuous-flow (CF) left ventricular assist device (LVAD) patients. EVAHEART (SunMedical Technology Research Co., Japan) LVAD is an implantable centrifugal blood pump which has characterized by relatively low share stress pump. Aim of this study was to investigate the vWF activities in our new pump.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
